Coincidentally, in 2021, researchers found that up-regulated hsa-miR-484 and hsa-miR-625-5p may inhibit the expression of AP2M1, thereby affecting AD (Li et al., 2021). The gene discussed is AP2M1; the disease is Alzheimer disease.